Unique ID issued by UMIN | UMIN000010277 |
---|---|
Receipt number | R000011208 |
Scientific Title | The intervention study of the swallowing exercise in patients with SBMA(spinal and bulbar muscular atrophy) |
Date of disclosure of the study information | 2013/04/01 |
Last modified on | 2016/04/19 09:19:13 |
The intervention study of the swallowing exercise in patients with SBMA(spinal and bulbar muscular atrophy)
swallowing exercise in SBMA
The intervention study of the swallowing exercise in patients with SBMA(spinal and bulbar muscular atrophy)
swallowing exercise in SBMA
Japan |
spinal and bulbar muscular atrophy (SBMA)
Neurology |
Others
NO
To evaluate the efficacy and safety of the head lift exercise (Shaker Exercise) in patients with spinal and bulbar muscular atrophy (SBMA)
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
severity score of the laryngeal penetration in videofluorography
1)Pharyngeal and oral barium residue (%) in videofluorography
2)stage transition duration, duration of opening upper esophageal sphincter, laryngeal elevation duration, times of swallowing in videofluorography
3)Dysphagia Function Questionnaire
4)motor functional scales
5)serum examination(serum substance P)
6)measurment of tongue pressure
7)Tongue MRI
Interventional
Single arm
Non-randomized
Open -but assessor(s) are blinded
No treatment
1
Treatment
Behavior,custom |
Shaker Exercise
20 | years-old | <= |
80 | years-old | > |
Male
1)Patients (males) in a genetic test with number of the CAG repeat of the androgen receptor gene more than 38
2)Patients with muscle weakness due to a lower motor neuron
3)Patients are between20 and 80 years old at the time of the agreement acquisition
4)Patients who are capable of ambulatory hospital visits
5)Patient with written informed consent
1)Patients who have taken LH-RH agonists, an LH-RH antagonists, testosterone drugs, anti-androgen drugs, estrogen drugs or unapproved drugs within 48 weeks before agreement acquisition and patients who have taken 5-alpha-reductase inhibitors within 24 weeks before agreement acquisition.
2)Patient who have undergone operations(eg. orchiectomy), which reduce serum testosterone levels.
3)Patients who have severe complications.
4)Patients who can not do neck flexion in a decubitus.
5)Patients who have undergone operations of the head and neck including cervical spine.
6)Patients who are not appropriate to participate to the trial.
7)Patients who are unable to undergo videofluorography.
8)Patient who are unable to undergo MRI inspection.
10
1st name | |
Middle name | |
Last name | Gen Sobue |
Nagoya University Graduate School of Medicine
Department of Neurology
65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 Japan
052-744-2390
1st name | |
Middle name | |
Last name | Tomoo Mano |
Department of Neurology
JASMITT clinical trial office
052-744-2390
JASMITT clinical trial office, Department of Neurology, Nagoya University Graduate School of Medicine
grants from the Ministry of Health, Labor and Welfare of Japan; and Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)
NO
名古屋大学病院(愛知県)
2013 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2012 | Year | 06 | Month | 28 | Day |
2012 | Year | 06 | Month | 28 | Day |
2013 | Year | 06 | Month | 28 | Day |
2013 | Year | 10 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 03 | Month | 19 | Day |
2016 | Year | 04 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011208